外化护士主导的模型用于型肝炎病毒的微分泌和毒品使用情况的影响
Anna Miralpeix1, Paula Ibáñez2, Víctor Navarro2
1Liver Unit, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
概括
一个由护士领导的项目成功地治疗了注射药物 (PWID) 的人的C型肝炎病毒 (HCV),证明了有效的HCV消除策略. 这种方法在成和减少危害服务中整合了诊断和治疗.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 直接作用的抗病毒药物已经在C型肝炎病毒 (HCV) 治疗中取得了先进.
- 实现世卫组织的HCV消除目标需要加强注射药物使用者 (PWID) 诊断和治疗的机会.
- 在成和减少伤害中心实施了一个外部化的,由护士驱动的模型,以弥合这一差距.
研究的目的:
- 建立和评估护士驱动的医疗保健电路,用于在PWID中诊断和治疗HCV.
- 评估在成和减少危害的环境中综合HCV护理的可行性和有效性.
主要方法:
- 一个由护士领导的团队在成中心 (AC) 和减少危害中心 (HRC) 为使用者提供HCV查,诊断和治疗.
- 远程肝科医生处方指导药物管理,用于活跃的感染.
- 同时提供教育和减少伤害的干预措施.
主要成果:
- 在接受查的566名用户中,有134人 (24%) 患有活跃的HCV感染,HRC组的患病率更高 (42%对17%).
- 持续病毒响应 (SVR) 率为70% (治疗意图) 和88% (按协议).
- 与HRC用户 (55%) 相比,AC用户 (81%) 的SVR更高,HRC组中发生了再感染.
结论:
- 一个以患者为中心,由护士驱动的模型可以成功地为PWID提供HCV治疗,即使是那些有复杂的社会经济状况和积极使用毒品的人.
- 根据用户特定特征调整干预措施对于最大限度地提高治疗成功和实现HCV消除目标至关重要.
相关概念视频
Drug Elimination: Non-Renal Routes
2.3K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.3K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
32
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
32
Hepatic Drug Excretion: Enterohepatic Cycling
1.0K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.0K
Drug Elimination: The Concept of Clearance
2.5K
Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
2.5K
Enhanced Elimination of Poison
478
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
478
Drug Elimination: Overview
1.1K
Drug elimination involves many complex processes and does not necessarily differentiate between distribution and elimination. It is divided into two primary components: excretion and biotransformation.
Excretion refers to removing a drug from the body, either in its unchanged form or as its metabolites. Nonvolatile and polar drugs are primarily excreted through the kidneys, with other pathways including bile, sweat, saliva, and milk. Volatile drugs such as anesthetic gases are excreted via the...
Excretion refers to removing a drug from the body, either in its unchanged form or as its metabolites. Nonvolatile and polar drugs are primarily excreted through the kidneys, with other pathways including bile, sweat, saliva, and milk. Volatile drugs such as anesthetic gases are excreted via the...
1.1K


